Opioid Use Disorder and Withdrawal NCLEX Questions With Rationales
What it is
Opioid use disorder (OUD) is a chronic, treatable condition characterized by problematic opioid use that causes clinically significant impairment or distress. Opioid withdrawal occurs when a physically dependent individual reduces or stops opioid use. Withdrawal is extremely uncomfortable but is rarely life-threatening in otherwise healthy adults. Opioid overdose, however, is a medical emergency because respiratory depression can cause hypoxia, brain injury, and death.
What the NCLEX focuses on
- Opioid overdose findings include decreased level of consciousness, inability to awaken, slow or absent breathing, pinpoint pupils, limp muscles, and blue or pale skin.
- Naloxone is an opioid antagonist that temporarily reverses opioid-induced respiratory depression and sedation. Emergency medical services must be activated, and additional naloxone may be needed if respiratory depression persists or returns.
- Naloxone may wear off before the opioid does, so recurrent sedation and respiratory depression can occur after initial improvement. Continued respiratory monitoring and emergency evaluation are essential.
- Opioid withdrawal commonly causes yawning, tearing, rhinorrhea, sweating, gooseflesh, dilated pupils, muscle aches, anxiety, nausea, vomiting, and diarrhea.
- Opioid withdrawal can cause dehydration and electrolyte disturbances from vomiting and diarrhea, although uncomplicated withdrawal is rarely life-threatening.
- The Clinical Opiate Withdrawal Scale (COWS) is an 11-item assessment tool that measures objective and subjective withdrawal findings and helps clinicians evaluate withdrawal severity.
- Methadone is a long-acting full opioid agonist that reduces withdrawal symptoms and cravings. It requires careful monitoring for sedation and respiratory depression.
- Buprenorphine is a partial opioid agonist that reduces cravings and withdrawal symptoms. Starting it too early after full opioid agonist use can precipitate withdrawal.
- Naltrexone is an opioid antagonist that blocks opioid effects and requires an adequate opioid-free period before initiation to prevent precipitated withdrawal.
Priority nursing actions
- For suspected overdose, assess responsiveness and breathing, activate emergency response, support the airway and ventilation, and administer naloxone according to the emergency protocol.
- Repeat naloxone according to product instructions and clinical protocol if respiratory depression persists or returns. Continue monitoring because recurrent respiratory depression can occur.
- Assess withdrawal using vital signs, hydration status, gastrointestinal symptoms, mental status, and the COWS scale when indicated.
- Provide prescribed supportive treatment for nausea, diarrhea, muscle aches, and dehydration, and monitor fluid and electrolyte status.
- Administer prescribed medication for OUD, monitor for adverse effects, and coordinate ongoing addiction treatment and follow-up care.
- Use nonjudgmental communication, maintain confidentiality, assess overdose risk, and offer naloxone education and harm-reduction resources.
Numbers to know
| Value | Number | Why it matters |
|---|---|---|
| Repeat naloxone assessment and dosing | 2 to 3 minutes | A second dose may be required if the person remains unresponsive and emergency responders have not arrived. |
| COWS assessment | 11 items, maximum score 48 | Measures the severity of opioid withdrawal. |
| COWS mild withdrawal | 5 to 12 | Indicates mild withdrawal. |
| COWS moderate withdrawal | 13 to 24 | Indicates moderate withdrawal. |
| Naltrexone initiation after short-acting opioids | 7 to 10 days | An opioid-free period is needed before treatment begins. |
| Naltrexone initiation after long-acting opioids | 10 to 14 days | A longer opioid-free period is generally required. |
Common exam traps
- Choosing to discharge a client immediately after naloxone reverses an overdose: wrong because naloxone may wear off before the opioid and respiratory depression can return.
- Choosing to treat opioid withdrawal as equivalent to opioid overdose: wrong because withdrawal generally causes autonomic and gastrointestinal symptoms rather than respiratory depression.
- Choosing to administer buprenorphine before adequate withdrawal develops: wrong because it can displace full opioid agonists and precipitate withdrawal.
- Choosing to start naltrexone while opioids remain in the client's system: wrong because opioid antagonism can precipitate severe withdrawal.
- Choosing to discontinue treatment because a client experiences relapse: wrong because OUD is treatable and continued medication and support can reduce overdose risk.
What to teach
- Teach clients and families to recognize slow breathing, inability to awaken, and pinpoint pupils as possible overdose findings.
- Explain how to administer naloxone, call emergency services, provide rescue breathing when indicated, and remain with the person until help arrives.
- Teach clients that tolerance decreases after abstinence or treatment interruption, increasing overdose risk if previous opioid doses are resumed.
- Explain that methadone, buprenorphine, and naltrexone are evidence-based treatment options and that treatment should be individualized.
- Encourage ongoing follow-up, recovery support, and access to naloxone even when treatment is going well.
2 NCLEX questions with rationales on this topic
From the NCLEXPace question bank. Choose your answer first, then open the correct answer and the full rationale under each question.
A client admitted 12 hours ago for opioid withdrawal reports nausea, diarrhea, muscle aches, and yawning frequently. Which nursing action is most appropriate?
Select the best answer.
- A. Avoid all withdrawal medications so the body clears the opioid naturally
- B. Administer symptom-directed medications and provide supportive care
- C. Explain that these mild symptoms resolve rapidly without treatment
- D. Discharge the client to finish the withdrawal at home
Show the correct answer and rationale
Correct answer:
- B. Administer symptom-directed medications and provide supportive care
Rationale
Overview
- Definition: Opioid withdrawal is a syndrome of autonomic, gastrointestinal, and neurobehavioral symptoms after cessation or reduction of opioids in a physiologically dependent person.
- Signs and timeline: Yawning, lacrimation, rhinorrhea, mydriasis, piloerection, muscle aches, nausea, diarrhea, anxiety, and insomnia occur. Short-acting opioid withdrawal often peaks within 48 to 72 hours after the last dose.
- Treatment: Symptom-directed medications, hydration, and supportive care reduce distress. Buprenorphine or methadone provides evidence-based treatment for opioid use disorder.
Nursing key points
- Identify the last opioid used, dose, route, and time of last administration.
- Assess withdrawal severity with the Clinical Opiate Withdrawal Scale (COWS).
- Administer prescribed clonidine or lofexidine for autonomic symptoms while monitoring blood pressure.
- Provide prescribed antiemetics, loperamide, analgesics, and oral or IV fluids as indicated.
- Administer buprenorphine or methadone according to the treatment protocol.
- Monitor hydration, electrolytes when indicated, mental status, and ongoing treatment needs.
Answer analysis
| Nursing action | Rationale |
|---|---|
| Avoid all withdrawal medications so the body clears the opioid naturally | Not correct. Withholding prescribed treatment increases distress without improving recovery. |
| Administer symptom-directed medications and provide supportive care | Correct. Medication, hydration, and clinical monitoring address withdrawal symptoms and prevent complications. |
| Explain that these mild symptoms resolve rapidly without treatment | Not correct. Withdrawal causes substantial distress and fluid loss and requires reassessment. |
| Discharge the client to finish the withdrawal at home | Not correct. Discharge requires clinical assessment and a safe ongoing treatment plan. |
Naltrexone is being considered to prevent relapse to opioid use. For each client scenario, indicate whether naltrexone can be safely started now or should be delayed.
| Can safely start now | Should be delayed | |
|---|---|---|
| Client fully detoxified from opioids, no opioid use for 7-10 days, negative urine drug screen | ||
| Client is currently experiencing active opioid withdrawal symptoms | ||
| Client has been off all opioids for more than two weeks with negative screens | ||
| Client took a small dose of an opioid earlier today for pain |
Show the correct answer and rationale
Correct answers:
- Client fully detoxified from opioids, no opioid use for 7-10 days, negative urine drug screen: Can safely start now
- Client is currently experiencing active opioid withdrawal symptoms: Should be delayed
- Client has been off all opioids for more than two weeks with negative screens: Can safely start now
- Client took a small dose of an opioid earlier today for pain: Should be delayed
Rationale
Overview
- Definition: Naltrexone is a competitive opioid receptor antagonist used to prevent relapse in opioid use disorder. It is available as daily oral therapy or extended-release monthly intramuscular injection.
- When it can start: Initiation requires complete opioid detoxification, typically at least 7 to 10 opioid-free days for short-acting opioids and longer intervals for long-acting opioids such as methadone. Clinical assessment, toxicology testing, and a challenge test when indicated establish readiness.
- Why timing matters: Naltrexone precipitates acute withdrawal when physiological opioid dependence persists. Reduced opioid tolerance increases overdose risk after treatment interruption or attempts to overcome receptor blockade.
Nursing key points
- Verify the specific opioid used, last dose, withdrawal resolution, and required opioid-free interval.
- Confirm negative appropriate toxicology results and assess contraindications before initiation.
- Delay treatment during active withdrawal or after recent opioid administration.
- Assess hepatic health and review prescribed opioid analgesics before treatment.
- Teach reduced opioid tolerance, overdose prevention, and access to naloxone.
Answer analysis
| Client scenario | Column | Rationale |
|---|---|---|
| Client fully detoxified from opioids, no opioid use for 7-10 days, negative urine drug screen | Can safely start now. | Full detoxification and the stated interval meet typical short-acting opioid initiation criteria, subject to final clinical screening. |
| Client is currently experiencing active opioid withdrawal symptoms | Should be delayed. | Active withdrawal requires stabilization and confirmation that physiological dependence has resolved. |
| Client has been off all opioids for more than two weeks with negative screens | Can safely start now. | Sustained opioid abstinence and negative screens support initiation after confirming withdrawal resolution and contraindications. |
| Client took a small dose of an opioid earlier today for pain | Should be delayed. | Recent opioid exposure requires reassessment of the opioid-free interval, dependence status, and analgesic needs. |
The NCLEXPace bank has 3,200+ NCLEX questions with full rationales, sorted by topic, with your progress tracked as you practice. Create your account to start.
Create Account →More topics in Mental Health
Intimate Partner Violence NCLEX Questions With RationalesCovers IPV recognition, screening, safety assessment, documentation, mandatory reporting, pregnancy risks, and nursing interventions.Grief and Loss NCLEX Questions With RationalesReviews normal and anticipatory grief, Kubler-Ross stages, prolonged grief, nursing interventions, suicide assessment, and age-appropriate bereavement support.Obsessive-Compulsive Disorder (OCD) NCLEX Questions With RationalesReviews OCD symptoms, nursing interventions, exposure and response prevention, medications, and client education.Sources
- Centers for Disease Control and Prevention. Responding to a Suspected Opioid Overdose. 2019.
- Substance Abuse and Mental Health Services Administration. Addressing Opioid Use Disorder in General Medical Settings. 2021.
- Substance Abuse and Mental Health Services Administration. Naltrexone. 2021.
- National Institute on Drug Abuse. Clinical Opiate Withdrawal Scale. 2003.
3,200+ NCLEX questions with think-like-a-nurse rationales, unfolding case studies and adaptive readiness exams. Start with free practice questions, then choose a plan when you are ready.
Create Account →